Literature DB >> 19369330

Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro.

Kazuo Sugiyama1, Kenji Suzuki, Takahide Nakazawa, Kenji Funami, Takayuki Hishiki, Kazuya Ogawa, Satoru Saito, Kumiko W Shimotohno, Takeshi Suzuki, Yuko Shimizu, Reiri Tobita, Makoto Hijikata, Hiroshi Takaku, Kunitada Shimotohno.   

Abstract

Replication and infectivity of hepatitis C virus (HCV) with a defective genome is ambiguous. We molecularly cloned 38 HCV isolates with defective genomes from 18 patient sera. The structural regions were widely deleted, with the 5' untranslated, core, and NS3-NS5B regions preserved. All of the deletions were in frame, indicating that they are translatable to the authentic terminus. Phylogenetic analyses showed self-replication of the defective genomes independent of full genomes. We generated a defective genome of chimeric HCV to mimic the defective isolate in the serum. By using this, we demonstrated for the first time that the defective genome, as it is circulating in the blood, can be encapsidated as an infectious particle by trans complementation of the structural proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369330      PMCID: PMC2698526          DOI: 10.1128/JVI.02674-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase.

Authors:  Chun-Jen Chen; Kazuo Sugiyama; Hideyuki Kubo; Cheng Huang; Shinji Makino
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells.

Authors:  K Sugiyama; N Kato; T Mizutani; M Ikeda; T Tanaka; K Shimotohno
Journal:  J Gen Virol       Date:  1997-02       Impact factor: 3.891

3.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

4.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

5.  Persistent infection of Vero cells by the flavivirus Murray Valley encephalitis virus.

Authors:  M Poidinger; R J Coelen; J S Mackenzie
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

6.  Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles.

Authors:  Eike Steinmann; Christiane Brohm; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

7.  Subgenomic replicon derived from a cell line infected with the hepatitis C virus.

Authors:  Hiroe Kishine; Kazuo Sugiyama; Makoto Hijikata; Nobuyuki Kato; Hitoshi Takahashi; Takeshi Noshi; Yasunori Nio; Masahiro Hosaka; Yusuke Miyanari; Kunitada Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

Review 8.  Hepatitis C virus as a causative agent of hepatocellular carcinoma.

Authors:  K Shimotohno
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

9.  Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective interfering particles by resistant cultures.

Authors:  M A Brinton
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

10.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

View more
  23 in total

1.  Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events.

Authors:  Konstantina Katsarou; Alexandros Alpha Lavdas; Panagiota Tsitoura; Elisavet Serti; Panagiotis Markoulatos; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

2.  Genetic Analysis of Serum-Derived Defective Hepatitis C Virus Genomes Revealed Novel Viral cis Elements for Virus Replication and Assembly.

Authors:  Qingchao Li; Yimin Tong; Yongfen Xu; Junqi Niu; Jin Zhong
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 3.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

4.  Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.

Authors:  Elisavet Serti; Polyxeni P Doumba; George Thyphronitis; Panagiota Tsitoura; Konstantina Katsarou; Pelagia Foka; Manousos M Konstandoulakis; John Koskinas; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

5.  Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.

Authors:  Yoshimi Shimizu; Yoshitaka Shirasago; Masuo Kondoh; Tetsuro Suzuki; Takaji Wakita; Kentaro Hanada; Kiyohito Yagi; Masayoshi Fukasawa
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  Hepatitis C virus utilizes VLDLR as a novel entry pathway.

Authors:  Saneyuki Ujino; Hironori Nishitsuji; Takayuki Hishiki; Kazuo Sugiyama; Hiroshi Takaku; Kunitada Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-23       Impact factor: 11.205

7.  Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.

Authors:  Takahiro Masaki; Ryosuke Suzuki; Mohsan Saeed; Ken-ichi Mori; Mami Matsuda; Hideki Aizaki; Koji Ishii; Noboru Maki; Tatsuo Miyamura; Yoshiharu Matsuura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

8.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

9.  High-Throughput Single-Cell Kinetics of Virus Infections in the Presence of Defective Interfering Particles.

Authors:  Fulya Akpinar; Andrea Timm; John Yin
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

10.  Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response.

Authors:  Cíntia Bittar; Ana Carolina G Jardim; Lilian H T Yamasaki; Artur T L de Queiróz; Claudia M A Carareto; João Renato R Pinho; Isabel Maria V G de Carvalho-Mello; Paula Rahal
Journal:  BMC Infect Dis       Date:  2010-02-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.